Cybelle Contraindications

Preparations containing estrogen/progestogen combinations should not be used in the presence of any of the conditions listed as follows. Should any of the conditions appear for the first time during their use, the product should be stopped immediately.
Presence or a history of venous or arterial thrombotic/thromboembolic events (e.g. deep venous thrombosis, pulmonary embolism, myocardial infarction) or of a cerebrovascular accident.
Presence or a history of prodromi of a thrombosis (e.g. transient ischaemic attack, angina pectoris).
A high risk of venous or arterial thrombosis (see 'Precautions').
History of migraine with focal neurological symptoms.
Diabetes mellitus with vascular involvement.
Severe hepatic disease as long as liver function values have not returned to normal.
Presence or history of liver tumors (benign or malignant).
Known or suspected sex-steroid influenced malignancies (e.g. of the genital organs or the breasts).
Undiagnosed vaginal bleeding.
Concomitant use with another hormonal contraceptive (see 'Indications').
Known or suspected pregnancy.
Lactation.
Hypersensitivity to the active substances or to any of the excipients.
CYBELLE 2mg/0.035mg is not for use in men.
CYBELLE 2mg/0.035mg is contraindicated for concomitant use with the medicinal products containing ombistavir/paritaprevir/ritonavir and dasabuvir (See Precautions).